lyle mcdonald glp-1 A few years ago it became clear to me that the GLP-1s were not only here to stay but, despite fitness industry hardheadeness, represented the first truly new development in the treatment The GLP-1 Solution: What You

Investments in research and development are robust, as pharmaceutical companies vie to capture market share in a sector with immense potential

Fixed Transparent Prices for 2026, GPhC Regulated, with ongoing clinical support.

Tongue pain, dryness, or white patches

February 4, 2026: Washington, DC A year ago, theNational Consumers League took the unusual step offlaggingwarningsfromthe Food and Drug Administration(FDA) and medical societiesstatingthatcompounded versions of GLP-1 (glucagon-like peptide-1 receptor agonists)weight-lossdrugs are not FDA approved and may cause serious health problems.The purposewas toinformconsumers aboutthe potential harm posed by these drugsbeforeHims & Hers, a large telehealth company,aired awidely hyped television ad duringthe 2025 Super Bowl touting only the benefitsof compoundedGLP-1s.